Histogen Announces Board Approval Of Complete Liquidation And Dissolution, Including Distribution Of Remaining Cash To Stockholders Following Operational Winddown; Co. Has Discontinued All Clinical Development Programs And Reduced Workforce
Author: Benzinga Newsdesk | September 18, 2023 03:06pm